Skip to content
Search

Latest Stories

Study links antacids in pregnancy to asthma in kids

Children of women who take heartburn medicine during pregnancy are a third more likely to develop asthma, according to a new study.

However, it remains unclear whether the medication itself, or some other factor, is responsible for that increased risk, researchers reported in the Journal of Allergy and Clinical Immunology.


“This association does not prove that the medicines caused asthma in these children,” said Aziz Sheikh, co-director of the Asthma UK Centre for Applied Research at the University of Edinburgh and co-author of the study.

“Further research is needed to better understand this link.”

Heartburn—discomfort caused by acid passing from the stomach up into the oesophagus—occurs frequently during pregnancy due to hormonal changes and pressure on the stomach from the expanding womb.

Certain drugs can block this acid reflux, and have long been thought not to affect the development of the baby.

Previous research had inconclusively pointed to an increased risk of allergies in offspring due to an impact on the immune system.

To dig deeper, scientists from Edinburgh and Finland reviewed eight previous studies involving more than 1.3 million children, drawing on healthcare registries and prescription databases.

They found that children born of mothers taking antacids were at least a third more likely to have visited a doctor for asthma symptoms.

Asthma is a chronic lung disease that inflames and narrows the airways. It frequently starts in childhood.

Symptoms include wheezing, shortness of breath and coughing.

More that 330 million people worldwide suffer from asthma, with an especially high incidence in low- and middle-income countries, according to The Global Asthma Report 2014.

Experts commenting on the study did not challenge the link between the heartburn drugs and asthma in kids, but cautioned against jumping to conclusions.

“It may be that the heartburn in itself may be the most important association rather than the drugs used to treat it,” said Jean Golding, an emeritus professor of paediatric epidemiology at the University of Bristol.

Obesity in the expecting mother could also play a key role, said Seif Shaheen, a respiratory epidemiologist at Queen Mary University of London, noting that few of the studies took this factor into account.

More For You

responsible antibiotic use campaign

Instead of leaning on alarming statistics, the campaign focuses on positivity

Onclusive

Andi Biotic returns with an upbeat campaign urging responsible antibiotic use

Highlights

  • UK Health Security Agency relaunches its mascot for World Antimicrobial Resistance Awareness Week
  • New campaign targets young adults with gym partnerships and a pharmacy-themed disco
  • Latest data shows antibiotic-resistant infections rise by 9.3% in England
  • Andi Biotic delivers key reminders on when antibiotics should and shouldn’t be used

Andi Biotic is back on duty

The UK Health Security Agency revives its popular red-and-white mascot Andi Biotic for World Antimicrobial Resistance Awareness Week, this time with a lively campaign aimed at young adults. The second phase of the Keep Antibiotics Working initiative launches today, using humour, dance moves and everyday settings to stress the importance of responsible antibiotic use.

The return comes as new figures show a growing challenge. The latest English Surveillance Programme for Antimicrobial Utilisation and Resistance report records a 9.3% rise in antibiotic-resistant infections over the past year, with nearly 400 people in England diagnosed each week.

Keep ReadingShow less